Last reviewed · How we verify
NCT04071340
The Natural History of Minimally Symptomatic Nonobstructing Calyceal Stones
trial testing non-contrast MSCT in Renal Stone in 96 participants. Completed in 1 July 2025.
1 June 2024
Quick facts
| Lead sponsor | Assiut University |
|---|---|
| Status | Completed |
| Study type | OBSERVATIONAL |
| Enrollment | 96 |
| Start date | 1 September 2019 |
| Primary completion | 1 June 2024 |
| Estimated completion | 1 July 2025 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- non-contrast MSCT
- Abdominal ultrasonography
- Urine analysis — full drug profile →
- Urine culture — full drug profile →
Conditions studied
- Renal Stone — all drugs for Renal Stone →
Sponsor
Assiut University
Who can join
Adults 18 to 100, any sex, with Renal Stone. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
* The primary aim is to study the natural history of single-calyx asymptomatic nonobstructing stone disease. * The Secondary aim is to determine the predictors of the need for intervention and of cure in such population.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT04071340
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Renal Stone
Currently open trials in the same condition.
- NCT07067996 — Erector Spinae Plane Block for Analgesia During ESWL · NA · recruiting
- NCT06786715 — Retrograde Intrarenal Surgery (RIRS) With Suction · NA · active not recruiting
- NCT06660914 — Robotic Flexible Ureteroscopy Versus Standard Flexible Ureteroscopy for Renal Stones · NA · recruiting
- NCT05894668 — Perioperative Parameter and Treatment Outcomes of ECIRS in Asia · recruiting
- NCT05697250 — High Versus Low Power Settings During Ureteroscopic Laser Lithotripsy · NA · recruiting
Other Assiut University trials
Trials by the same sponsor.
- NCT07423312 — Lead Exposure and Multiple Sclerosis · not yet recruiting
- NCT07234526 — Usage of Glucose Fluctuations as a Prognostic Marker in Septic Shock Patients · not yet recruiting
- NCT07273214 — Knowledge, Attitude and Practice of Third Trimester Pregnant Mothers Towards Self-Medication in Assiut, Egypt · not yet recruiting
- NCT07194863 — Efficacy of Essential Phospholipid Versus Betaine HCL/L-Glutamic Acid in MAFLD · not yet recruiting
- NCT07053709 — Screening for Hyperuricemia in Patients With Metabolic Associated Fatty Liver Disease (MAFLD) · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT04071340 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Assiut University
- Last refreshed: 23 July 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04071340.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing